References
- Holdstock G, Savage D, Harman M, Wright R. Should patients with inflammatory bowel disease smoke?. Br Med J 1984; 288: 362
- Thornton J R, Emmett P M, Heaton KW. Smoking, sugar and inflammatory bowel disease. Br Med J 1985; 290: 1786–7
- Vessey M, Jewell D, Smith A, Yeats D, McPherson K. Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of childbearing age. Br Med J 1986; 292: 1101–3
- Franceschi S, Panza E, La Vecchia C, Parazini F, Decarli A, Porro GB. Non-specific inflammatory bowel disease and smoking. Am J Epidemiol 1987; 125: 445–52
- Tobin M V, Logan R FA, Langman M JS, McConnell R B, Gil-More IT. Cigarette smoking and inflammatory bowel disease. Gastroenterology 1987; 93: 316–21
- Benoni C, Nilsson Å. Smoking habits in patients with inflammatory bowel disease. A case control study. Scand J Gastroenterol 1987; 22: 1130–6
- Lindberg E, Tysk C, Andersson K, Järnerot G. Smoking and inflammatory bowel disease A case control study. Gut 1988; 29: 352–7
- Tysk C, Lindberg E, Järnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988; 29: 990–6
- Silverstein M D, Lashner B A, Hanauer S B, Evans A A, Kirsner JB. Cigarette smoking in Crohn's disease. Am J Gastroenterol 1989; 84: 31–3
- Persson P-G, Ahlbom A, Hellers G. Inflammatory bowel disease and tobacco smoke—a case-control study. Gut 1990; 31: 1377–81
- Hollander D. Crohn's disease—a permeability disorder of the tight junction?. Gut 1988; 29: 1621–4
- Cobden I, Rothwell J, Axon A TR. Intestinal permeability and screening tests for coeliac disease. Gut 1980; 21: 512–8
- Pearson A DJ, Eastham E J, Laker M F, Craft A W, Nelson R. Intestinal permeability in children with Crohn's disease and coeliac disease. Br Med J 1982; 285: 20–1
- Bjarnarson I, O'Morain C, Levi A J, Peters TJ. Absorption of 51-chromium-labelled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology 1983; 85: 318–22
- Ukabam S O, Cooper BT. Small intestinal permeability to man-nitol, lactulose and polyethyleneglycol 400 in celiac dsease. Dig Dis Sci 1984; 29: 809–16
- O'Morain C A, Abelov C A, Cheruu L R, Fleischner GM. Chromium 51-ethylenediaminetetraacetate: a useful test in the assessment of inflammatory bowel disease. J Lab Clin Med 1986; 108: 430–5
- Hollander D, Vadheim C M, Brettholz E, Petersen G M, Dela-Hunty T, Rotter JI. Increased intestinal permeability in patients with Crohn's disease and their relatives—a possible etiologic factor. Ann Intern Med 1986; 105: 883–5
- Jenkins R T, Goodrace R L, Rooney P J, Bienenstock J, Sivak-Umaran T, Walker W HC. Studies of intestinal permeability in inflammatory diseases using polyethylene glycol 400. Clin Biochem 1986; 19: 298–302
- Olaison G, Sjodahl R, Tagesson C. Decreased gastrointestinal absorption of peroral polyethylene glycols (PEG 1000) in Crohn's disease—a sign of jejunal abnormality. Acta Chir Scand 1987; 153: 373–7
- Olaison G, Leandersson P, Sjodahl R, Tagesson C. Intestinal permeability to polyethyleneglycols 600 in Crohn's disease. Per-operative determination in a defined segment of the small intestine. Gut 1988; 29: 196–9
- Olaison G, Sjodahl R, Leandersson P, Tagesson C. Abnormal intestinal permeability pattern in colonic Crohn's disease. Absorption of low molecular weight polyethylene glycols after oral and colonic load. Scand J Gastroenterol 1989; 24: 571–6
- Pera A, Bellando P, Caldera V, et al. Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology 1987; 92: 181–5
- Morson BC. Histopathology of Crohn's disease. Proc R Soc Med 1968; 61: 79–81
- Tagesson C, Andersson P-A, Andersson T, Bolin T, Kallberg M, Sjodahl R. Passage of molecules through the wall of the gastrointestinal tract. Measurement of intestinal permeability to polyethylene glycols in the 634–1338-dalton range (PEG 1000). Scand J Gastroenterol 1983; 18: 481–6
- Dunne W T, Cooke W T, Allan RN. Enzymatic and morphometry evidence for Crohn's disease as a diffuse lesion of the gastrointestinal tract. Gut 1977; 18: 290–4
- Menzies IS. Transmucosal passage of inert molecules in health and disease. Intestinal absorption and secretion, E Skadhauge, K Heintze. MTP Press Ltd, Lancaster 1983; 527–43
- Prytz H, Benoni C, Tagesson C. Does smoking tighten the gut?. Scand J Gastroenterol 1989; 24: 1084–8
- Maxton D G, Bjarnarson I, Reynolds A P, Catt S D, Peters T J, Menzies IS. Lactulose, 51Cr-labeled ethylenediaminetetra-acetate, 1-rhamnose and polyethyleneglycol 400 as probe-makers for assessment in vivo of human intestinal permeability. Clin Sci 1986; 71: 71–80
- Wakefield A J, Sawyerr A M, Dhillon A P, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989; 2: 1057–62
- Wakefield A J, Sankey E A, Dhillon A P, et al. Granulomatous vasculitis in Crohn's disease. Gastroenterology 1991; 100: 1279–87
- Quimby G F, Bonnice C A, Burstein S H, Eastwood GL. Active smoking depresses prostaglandin synthesis in human gastric mucosa. Ann Intern Med 1986; 104: 616–9